Reference

1. McCarthy M. Therapeutic strategies to address monkeypox. Expert Review of Anti-infective Therapy. 2022;20(10):1249-1252.
2. Reynolds M, Doty J, McCollum A, Olson V, Nakazawa Y. Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health. Expert Review of Anti-infective Therapy. 2019;17(2):129-139.
3. Nolen L, Tamfum J, Kabamba J, Likofata J, Katomba J, McCollum A et al. Introduction of Monkeypox into a Community and Household: Risk Factors and Zoonotic Reservoirs in the Democratic Republic of the Congo. The American Journal of Tropical Medicine and Hygiene. 2015;93(2):410-415.
4. McCarthy M. Recent advances in the diagnosis monkeypox: implications for public health. Expert Review of Molecular Diagnostics. 2022;22(7):739-744.
5. Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y et al. Outbreak of human monkeypox in Nigeria in 2017—18: a clinical and epidemiological report. The Lancet Infectious Diseases. 2019;19(8):872-879.
6. Cho C, Wenner H. Monkeypox virus. Bacteriological Reviews. 1973;37(1):1-18.
7. Weinstein R, Nalca A, Rimoin A, Bavari S, Whitehouse C. Reemergence of Monkeypox: Prevalence, Diagnostics, and Countermeasures. Clinical Infectious Diseases. 2005;41(12):1765-1771.Taxonomy and classification
8. Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Cureus. 2022;.
9. Ghazanfar, A. (2022) “Epidemiology, clinical features, diagnosis and management of Monkeypox virus: A clinical review article,” Cureus [Preprint]. Available at: https://doi.org/10.7759/cureus.28598.
10. Benites-Zapata V, Ulloque-Badaracco J, Alarcon-Braga E, Hernandez-Bustamante E, Mosquera-Rojas M, Bonilla-Aldana D et al. Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 2022;21(1).
11. Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerging Microbes & Infections. 2022;11(1):1768-1777.
12. Focosi D, Novazzi F, Baj A, Maggi F. Monkeypox: An international epidemic. Reviews in Medical Virology. 2022;.
13. Adnan N, Haq Z, Malik A, Mehmood A, Ishaq U, Faraz M et al. Human monkeypox virus: An updated review. Medicine. 2022;101(35):e30406.
14. Alakunle E, Moens U, Nchinda G, Okeke M. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses. 2020;12(11):1257
15. Damon I. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011;29:D54-D59.
16. Kmiec D, Kirchhoff F. Monkeypox: A New Threat?. International Journal of Molecular Sciences. 2022;23(14):7866.
17. Parvin R, Ali A, Nagy A, Zhu Z, Zhao S, Paul A et al. Monkeypox virus: A comprehensive review of taxonomy, evolution, epidemiology, diagnosis, prevention, and control regiments so far. German Journal of Microbiology. 2022;2(2):1-15.
18. Kandi, V. and Vadakedath, S. (2023) ‘Clinical trials and clinical research: A comprehensive review’, Cureus [Preprint]. doi:10.7759/cureus.35077.
19. Farahat R, Ali I, AL- Ahdal T, Benmelouka A, Albakri K, El-Sakka A et al. Monkeypox and human transmission: Are we on the verge of another pandemic?. Travel Medicine and Infectious Disease. 2022;49:102387
20. Alakunle, E. et al. (2020) ‘Monkeypox virus in Nigeria: Infection Biology, Epidemiology, and evolution’, Viruses, 12(11), p. 1257. doi:10.3390/v12111257.
21. Ola, P. (2022) The origin of the mysterious multi-country monkeypox outbreak in non-endemic countries [Preprint]. doi:10.22541/au.165426607.74780750/v1.
22. McFadden G. Poxvirus tropism. Nature Reviews Microbiology. 2005;3(3):201-213.
23. Hsiao J, Chung C, Chang W. Vaccinia Virus Envelope D8L Protein Binds to Cell Surface Chondroitin Sulfate and Mediates the Adsorption of Intracellular Mature Virions to Cells. Journalof Virology. 1999;73(10):8750-8761.
24. Realegeno S, Puschnik A, Kumar A, Goldsmith C, Burgado J, Sambhara S et al. Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation. Journal of Virology. 2017;91(11).
25. Challberg M, Englund P. Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus. Journal of Biological Chemistry. 1979;254(16):7812-7819.
26. Kmiec D, Kirchhoff F. Monkeypox: A New Threat?. International Journal of Molecular Sciences. 2022;23(14):7866.
27. Parvin R, Ali A, Nagy A, Zhu Z, Zhao S, Paul A et al. Monkeypox virus: A comprehensive review of taxonomy, evolution, epidemiology, diagnosis, prevention, and control regiments so far. German Journal of Microbiology. 2022;2(2):1-15.
28. Kumar N, Acharya A, Gendelman H, Byrareddy S. The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of Autoimmunity. 2022;131:102855.
29. Schnierle B. Monkeypox Goes North: Ongoing Worldwide Monkeypox Infections in Humans. Viruses. 2022;14(9):1874.
30. Chadha J, Khullar L, Gulati P, Chhibber S, Harjai K. Insights into the monkeypox virus: Making of another pandemic within the pandemic?. Environmental Microbiology. 2022;.
31. Kumar N, Acharya A, Gendelman H, Byrareddy S. The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of Autoimmunity. 2022;131:102855.
32. Kmiec D, Kirchhoff F. Monkeypox: A New Threat?. International Journal of Molecular Sciences. 2022;23(14):7866.
33. Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerging Microbes & Infections. 2022;11(1):1768-1777.
34. Di Giulio D, Eckburg P. Human monkeypox: an emerging zoonosis. The Lancet Infectious Diseases. 2004;4(1):15-25.
35. Lum F, Torres-Ruesta A, Tay M, Lin R, Lye D, Rénia L et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022;22(10):597-613.
36. Chadha J, Khullar L, Gulati P, Chhibber S, Harjai K. Insights into the monkeypox virus: Making of another pandemic within the pandemic?. Environmental Microbiology. 2022;.
37. McCollum A, Damon I. Human Monkeypox. Clinical Infectious Diseases. 2013;58(2):260-267.
38. Cheema A, Ogedegbe O, Munir M, Alugba G, Ojo T. Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2022;.
39. Titanji B, Tegomoh B, Nematollahi S, Konomos M, Kulkarni P. Monkeypox: A Contemporary Review for Healthcare Professionals. Open Forum Infectious Diseases. 2022;9(7).
40. Weinstein R, Nalca A, Rimoin A, Bavari S, Whitehouse C. Reemergence of Monkeypox: Prevalence, Diagnostics, and Countermeasures. Clinical Infectious Diseases. 2005;41(12):1765-1771.
41. Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Cureus. 2022;.
42. Lum F, Torres-Ruesta A, Tay M, Lin R, Lye D, Rénia L et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022;22(10):597-613.
43. Titanji B, Tegomoh B, Nematollahi S, Konomos M, Kulkarni P. Monkeypox: A Contemporary Review for Healthcare Professionals. Open Forum Infectious Diseases. 2022;9(7).
44. See K. Vaccination for Monkeypox Virus Infection in Humans: A Review of Key Considerations. Vaccines. 2022;10(8):1342.
45. Di Giulio D, Eckburg P. Human monkeypox: an emerging zoonosis. The Lancet Infectious Diseases. 2004;4(1):15-25.
46. Reynolds M, McCollum A, Nguete B, Shongo Lushima R, Petersen B. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 2017;9(12):380.
47. Adler, H. and Taggart, R. (2022) ‘Monkeypox exposure during pregnancy: What does UK Public Health Guidance Advise?’, The Lancet, 400(10362), p. 1509. doi:10.1016/s0140-6736(22)01794-9.
48. Rizk J, Lippi G, Henry B, Forthal D, Rizk Y. Prevention and Treatment of Monkeypox. Drugs. 2022;82(9):957-963
49. Russo A, Grosenbach D, Chinsangaram J, Honeychurch K, Long P, Lovejoy C et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Review of Anti-infective Therapy. 2020;19(3):331-344.
50. Chittick G, Morrison M, Brundage T, Nichols W. Short-term clinical safety profile of brincidofovir: A favorable benefit—risk proposition in the treatment of smallpox. Antiviral Research. 2017;143:269-277.
51. Rice A, Adams M, Lampert B, Foster S, Lanier R, Robertson A et al. Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans. Viruses. 2015;3(2):63-82.
52. Smee D. Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models. Antiviral Chemistry and Chemotherapy. 2008;19(3):115-124